{"transactions":[{"id":1919143,"issuer":{"id":135,"kind":"organization","name":"Grove Collaborative Holdings, Inc.","symbol":"GROV"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":5,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-04-17T21:18:50.000Z","date":"2023-04-13","kind":"other","planned":false,"acquired":true,"shares":135480,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Norwest Venture Partners XIII, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents the automatic increase, for no additional consideration, in the number of shares of Class B Common Stock held by the Reporting Person as a result of the rebalancing of Earnout Shares following the forfeiture of certain equity awards of the Issuer by the holders thereof, as required by the Agreement and Plan of Merger, dated December 7, 2021, as amended and restated on March 31, 2022, by and among Virgin Group Acquisition Corp. II (\"VGAC II\"), two wholly owned direct subsidiaries of VGAC II, and Grove Collaborative, Inc.  This increase is exempt from Section 16 filing by virtue of the exemption provided by Rule 16a-9 and is being reported voluntarily."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents restricted shares of Class B Common Stock that will vest upon the achievement of certain earnout thresholds prior to June 16, 2032 (the \"Earnout Shares\") as follows: (i) 50% of the Earnout Shares automatically vest if the daily volume weighted average price (\"VWAP\") of the shares of Class A Common Stock is greater than or equal to $12.50 per share for any 20 trading days within any 30-trading-day period; and (ii) 50% of the Earnout Shares automatically vest if the daily VWAP of the shares of Class A Common Stock is greater than or equal to $15.00 per share for any 20 trading days within any 30-trading-day period, each subject to certain change-of-control provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and NVP Associates, LLC (\"NVP Associates\") is the managing member of Genesis XIII. Genesis XIII, NVP Associates and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power over the shares held by NVP XIII. Each of Genesis XIII, NVP Associates and Messrs. Crowe, Haque and Kossow disclaims beneficial ownership of the securities held by NVP XIII except to the extent of its or his pecuniary interest therein."}],"balance_after":1407876,"derivative":{"underlying":"Class A Common Stock","underlying_shares":135480},"source":{"system":"sec-edgar","filing":"0001209191-23-024567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919123024567/doc4.xml","form_type":"4"}},{"id":1919142,"issuer":{"id":135,"kind":"organization","name":"Grove Collaborative Holdings, Inc.","symbol":"GROV"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":5,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-04-17T21:18:50.000Z","date":"2022-11-23","kind":"exercise","planned":false,"acquired":false,"shares":14217512,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Norwest Venture Partners XIII, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Class B common stock were converted into Class A common stock on a one-for-one basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents restricted shares of Class B Common Stock that will vest upon the achievement of certain earnout thresholds prior to June 16, 2032 (the \"Earnout Shares\") as follows: (i) 50% of the Earnout Shares automatically vest if the daily volume weighted average price (\"VWAP\") of the shares of Class A Common Stock is greater than or equal to $12.50 per share for any 20 trading days within any 30-trading-day period; and (ii) 50% of the Earnout Shares automatically vest if the daily VWAP of the shares of Class A Common Stock is greater than or equal to $15.00 per share for any 20 trading days within any 30-trading-day period, each subject to certain change-of-control provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and NVP Associates, LLC (\"NVP Associates\") is the managing member of Genesis XIII. Genesis XIII, NVP Associates and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power over the shares held by NVP XIII. Each of Genesis XIII, NVP Associates and Messrs. Crowe, Haque and Kossow disclaims beneficial ownership of the securities held by NVP XIII except to the extent of its or his pecuniary interest therein."}],"balance_after":1272396,"derivative":{"underlying":"Class A Common Stock","underlying_shares":14217512},"source":{"system":"sec-edgar","filing":"0001209191-23-024567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919123024567/doc4.xml","form_type":"4"}},{"id":1919141,"issuer":{"id":135,"kind":"organization","name":"Grove Collaborative Holdings, Inc.","symbol":"GROV"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":5,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-17T21:18:50.000Z","date":"2022-11-23","kind":"exercise","planned":false,"acquired":true,"shares":14217512,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Norwest Venture Partners XIII, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Class B common stock were converted into Class A common stock on a one-for-one basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and NVP Associates, LLC (\"NVP Associates\") is the managing member of Genesis XIII. Genesis XIII, NVP Associates and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power over the shares held by NVP XIII. Each of Genesis XIII, NVP Associates and Messrs. Crowe, Haque and Kossow disclaims beneficial ownership of the securities held by NVP XIII except to the extent of its or his pecuniary interest therein."}],"balance_after":14717612,"source":{"system":"sec-edgar","filing":"0001209191-23-024567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919123024567/doc4.xml","form_type":"4"}},{"id":3558748,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to buy)","published_at":"2019-04-10T18:31:33.000Z","date":"2019-04-08","kind":"other","acquired":false,"shares":3764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Lines 1 and 2 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIII, and Promod Haque, Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Haque, Crowe, and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the shares subject to the warrant are fully exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":8.27,"expiration_date":"2024-12-21","underlying":"Common Stock","underlying_shares":3764},"source":{"system":"sec-edgar","filing":"0001209191-19-024306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919119024306/doc4.xml","form_type":"4"}},{"id":3558747,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-04-10T18:31:33.000Z","date":"2019-04-08","kind":"exercise","acquired":false,"shares":2458210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Lines 1 and 2 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIII, and Promod Haque, Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Haque, Crowe, and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2458210},"source":{"system":"sec-edgar","filing":"0001209191-19-024306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919119024306/doc4.xml","form_type":"4"}},{"id":3558746,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T18:31:33.000Z","date":"2019-04-08","kind":"other","acquired":true,"shares":3764,"price":8.27,"value":31128.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Lines 1 and 2 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIII, and Promod Haque, Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Haque, Crowe, and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":2461974,"source":{"system":"sec-edgar","filing":"0001209191-19-024306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919119024306/doc4.xml","form_type":"4"}},{"id":3558745,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T18:31:33.000Z","date":"2019-04-08","kind":"exercise","acquired":true,"shares":2458210,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Lines 1 and 2 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIII, and Promod Haque, Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Haque, Crowe, and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":2458210,"source":{"system":"sec-edgar","filing":"0001209191-19-024306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919119024306/doc4.xml","form_type":"4"}}]}